Q32 Bio (QTTB) Institutional Ownership → Breaking News: Elon Musk Invents New Type of A.I. (Shocking) (From InvestorPlace) (Ad) Free QTTB Stock Alerts $30.36 -0.64 (-2.06%) (As of 05/17/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesOwnershipSEC FilingsSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesOwnershipSEC FilingsSocial Media Institutional Ownership Changes (13F Filings) for Q32 Bio (NASDAQ:QTTB)CurrentInstitutional OwnershipPercentage31.32%Number ofInstitutional Buyers(last 12 months)10TotalInstitutional Inflows(last 12 months)$71.26MNumber ofInstitutional Sellers(last 12 months)0 Get QTTB Insider Trade Alerts Want to know when executives and insiders are buying or selling Q32 Bio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data QTTB Institutional Buying and Selling by Quarter Ad Crypto 101 MediaShocking $16T Elon Musk Crypto LeakReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy. Q32 Bio Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/17/2024 Ikarian Capital LLC22,335$381K0.0%N/A0.685% 5/15/2024 ARCH Venture Management LLC320,482$5.46M6.5%N/A9.831% 5/15/2024 Affinity Asset Advisors LLC27,777$473K0.1%N/A0.852% 5/14/2024 Platinum Investment Management Ltd.109,964$1.87M0.1%N/A3.373% 5/10/2024 Acadian Asset Management LLC3,695$62K0.0%N/A0.113% 5/10/2024 Vanguard Group Inc.107,752$1.84M0.0%N/A3.305% 5/6/2024 Atlas Venture Life Science Advisors LLC2,092,106$35.65M3.3%N/A64.254% 5/3/2024 Carlyle Group Inc.1,102,741$18.07M1.1%N/A33.826% 4/23/2024 BML Capital Management LLC24,894$424K0.3%N/A0.764% 4/22/2024 Vivo Capital LLC370,068$6.31M0.5%N/A11.366% (Data available from 1/1/2016 forward) QTTB Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of QTTB shares? During the previous two years, 10 institutional investors and hedge funds held shares of Q32 Bio. The most heavily invested institutionals were Atlas Venture Life Science Advisors LLC ($35.65M), Carlyle Group Inc. ($18.07M), Vivo Capital LLC ($6.31M), ARCH Venture Management LLC ($5.46M), Platinum Investment Management Ltd. ($1.87M), Vanguard Group Inc. ($1.84M), and Affinity Asset Advisors LLC ($473K).Learn more on QTTB's institutional investors. What percentage of Q32 Bio stock is owned by institutional investors? 31.32% of Q32 Bio stock is owned by institutional investors. Learn more on QTTB's institutional investor holdings. Which institutional investors have been buying Q32 Bio stock? Of the 10 institutional investors that purchased Q32 Bio stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Atlas Venture Life Science Advisors LLC ($2.09M), Carlyle Group Inc. ($1.10M), Vivo Capital LLC ($370.07K), ARCH Venture Management LLC ($320.48K), Platinum Investment Management Ltd. ($109.96K), Vanguard Group Inc. ($107.75K), and Affinity Asset Advisors LLC ($27.78K). How much institutional buying is happening at Q32 Bio? Institutional investors have bought a total of 4,181,814 shares in the last 24 months. This purchase volume represents approximately $71.26M in transactions. Related Companies: YS Biopharma Institutional Ownership Assertio Institutional Ownership Oramed Pharmaceuticals Institutional Ownership IO Biotech Institutional Ownership Annovis Bio Institutional Ownership Eton Pharmaceuticals Institutional Ownership ProPhase Labs Institutional Ownership Anixa Biosciences Institutional Ownership Genelux Institutional Ownership Clearside Biomedical Institutional Ownership This page (NASDAQ:QTTB) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaCrypto Pioneer Says: “The last crypto bull market has begun.”InvestorPlaceI’m afraid WWIII is a very real possibility Porter & CompanyPOTUS in ‘25 Not Biden/Trump, ButThe Freeport SocietyMissed NVDA? Buy this AI stock NOWChaikin AnalyticsUrgent Nvidia WarningAltimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Q32 Bio Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.